Texas Society of Psychiatric Physicians 66th Annual Convention and Scientific Program

Join us for the 66th Annual TSPP Convention and Scientific Program at the JW Marriott Houston by the Galleria!

Book your room before October 13 to receive a discounted room rate.

Problem or Panacea: Challenges, Risks and Benefits of Common Drugs of Abuse

November 12-13, 2022


Registration is Now Open!

Download a registration form to send to TSPP, or register online!

Full Conference Schedule


Nine (9) AMA PRA Category 1 CreditsTM

with 1 of the Hours Designated for Medical Ethics/Professional Responsibility

Behavioral Treatment of Substance Abuse – Joy Schmitz, PhD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • recognize patients with substance use disorders who would benefit from addition of behavioral treatments such as contingency management.
  • directly provide behavioral treatment (such as contingency management) or to make informed referrals to other providers who provide behavioral treatment for substance use disorders.
Smoking Cessation and Synthetic Nicotine – Maher Karam-Hage, MD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to identify, diagnose and treat tobacco use disorder in their practice as an essential part of their practice

Opioid Contaminants in Stimulants – Samantha Roseberry, PharmD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • identify that the use of illicit psychostimulants such as methamphetamine and cocaine has increased, particularly among those using opioids
  • recognize that those patients with stimulant use disorders may not necessarily spontaneously report that they are also using opioids
  • identify that stimulant co-use specifically methamphetamine, and stimulant co-involvement in overdose fatalities, including among people with opioid use disorder, are of growing concern in the USA and around the world
Therapeutic Use of Marijuana and Psychedelics: What Should I Tell my Patient? – Daryl Shorter, MD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • describe the current status of the evidence on the therapeutic use of marijuana and psychedelics in the treatment of mental illnesses
  • identify strategies aiming at optimizing the discussion and education of patients with regards to the available evidence mentioned above
Safety issues in the use of sedative-hypnotics, muscle relaxants and alcohol – Austin De La Cruz, PharmD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • identify that numerous classes of prescription medications can interact with alcohol, including antibiotics, antidepressants, antihistamines, barbiturates, benzodiazepines, histamine H2 receptor antagonists, muscle relaxants, nonnarcotic pain medications and anti-inflammatory agents, opioids, and warfarin
  • recognize that those patients with alcohol use may not necessarily spontaneously report that they are also using other CNS active medications
  • identify pharmacokinetic and pharmacodynamic interactions of the above medications with each other and with alcohol
  • recognize that many over-the-counter and herbal medications can cause negative effects when taken with alcohol.
The Opioid Overdose Epidemic – Andres A Avellaneda Ojeda, MD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • identify and diagnosis of opioid use disorder
  • identify pharmacologic interventions for opioid use disorder
  • multidisciplinary approach to treat pregnant patient with opioid use disorder
Ethical Perspectives on Psychiatric Treatment Selection – John Sadler, MD

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

  • explain why treatment selection is an ethical act
  • describe several relevant clinician virtues in psychiatric treatment selection
  • show how attention to clinician virtues assist in addressing patient values in evidence-based practice.

ACCREDITATION STATEMENT

The Texas Society of Psychiatric Physicians is accredited by the Texas Medical Association to provide continuing medical education for physicians.

FOR CME PROGRAM SYLLABUS ENTER CODE [Coming Soon]